MedTrace Logo

THRIVE Feasibility Trial

NCT05346588 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-11-24

No results posted yet for this study

Summary

To evaluate the feasibility of a pragmatic, large scale, comparative effectiveness, randomized evaluation of patient experience of intravenous propofol versus inhaled volatile anesthesia.

Conditions

  • Surgery--Complications
  • Anesthesia Complication
  • Anesthesia Awareness
  • Anesthesia Emergence Delirium
  • Anesthesia
  • Surgery
  • Quality of Life
  • Pain, Postoperative
  • Nausea, Postoperative
  • Anesthesia Morbidity
  • Depression
  • Sleep Disorders, Circadian Rhythm

Interventions

OTHER

Anesthetic technique Propofol TIVA

Propofol TIVA no inhaled agent

OTHER

Anesthetic technique inhaled agent

must administer inhaled agent.

Sponsors & Collaborators

Principal Investigators

  • Sachin Kheterpal, MD · University of Michigan

  • Michael S Avidan, MBBcH · Washington Univeristy

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-29
Primary Completion
2023-04-16
Completion
2023-06-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05346588 on ClinicalTrials.gov